Effect of different direct-acting antiviral regimens for treatment of nondiabetic hepatitis C virus–infected Egyptian patients on insulin resistance and sensitivity

Effect of different direct-acting antiviral regimens for treatment of nondiabetic hepatitis C virus–infected Egyptian patients on insulin resistance and sensitivity

Abstract Background The association between hepatitis C virus (HCV), insulin resistance (IR), and metabolic syndrome has been extensively investigated. Direct-acting antivirals (DAAs) have a high sustained virologic response (SVR) rate, reaching > 90%. The effect of SVR after DAA treatment on met...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tarek Yosef, Wesam Ahmed Ibrahim, Ahmed El-Ghandour, Soha Attia, Sarah El-Nakeep
Formato: article
Lenguaje:EN
Publicado: SpringerOpen 2021
Materias:
Hepatitis C virus
Direct-acting antivirals
Insulin resistance
Insulin sensitivity
HOMA-IR
Matsuda index
Internal medicine
RC31-1245
Acceso en línea:https://doaj.org/article/f074dadba7d641818293d546e4dc338e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f074dadba7d641818293d546e4dc338e

Ejemplares similares